These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9474949)
1. Combination therapy of tacrolimus (FK506) with azathioprine and steroids in renal transplant recipients. Yoshimura N; Oka T; Ohmori Y; Yasumura T; Nakai I; Hamashima T; Nakajima H; Okamoto M; Nakamura K; Mizuta N Transplant Proc; 1998 Feb; 30(1):33-5. PubMed ID: 9474949 [No Abstract] [Full Text] [Related]
2. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452 [TBL] [Abstract][Full Text] [Related]
3. Clinical study of FK 506 in renal transplant recipients. Youhua Z; Zhinlian M; Liming W Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900 [No Abstract] [Full Text] [Related]
4. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group. Miller J; Mendez R; Pirsch JD; Jensik SC Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543 [TBL] [Abstract][Full Text] [Related]
5. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735 [No Abstract] [Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
7. A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients-preliminary results. Machado PG; Garcia C; Felipe CR; Garcia R; Franco M; Delcelo R; Silva HT; Medina JO Transplant Proc; 2001; 33(1-2):1074-5. PubMed ID: 11267196 [No Abstract] [Full Text] [Related]
8. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation. Yu L; Wang Y; Fu SJ; Cheng XJ Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902 [No Abstract] [Full Text] [Related]
9. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415 [TBL] [Abstract][Full Text] [Related]
11. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients? Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256 [TBL] [Abstract][Full Text] [Related]
12. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. Sperschneider H; Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291 [No Abstract] [Full Text] [Related]
13. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. Walker RE; McCrindle BW; Coles JG; West LJ Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452 [No Abstract] [Full Text] [Related]
15. One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation. Calconi G; Vianello A; Transplant Proc; 2001; 33(1-2):1021-4. PubMed ID: 11267173 [No Abstract] [Full Text] [Related]
16. Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation. Okamoto M; Yoshimura N; Nakai I; Nakajima H; Ushigome H; Sakaguchi K; Ohmori Y; Yoshimura R; Sugioka N; Oka T Transplant Proc; 2000 Nov; 32(7):1716-7. PubMed ID: 11119905 [No Abstract] [Full Text] [Related]
17. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Friemann S; Feuring E; Padberg W; Ernst W Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504 [No Abstract] [Full Text] [Related]
18. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Bar J; Stahl B; Hod M; Wittenberg C; Pardo J; Merlob P Am J Med Genet A; 2003 Jan; 116A(1):31-6. PubMed ID: 12476448 [TBL] [Abstract][Full Text] [Related]
19. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. Pascual J; Ortuño J; Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198 [No Abstract] [Full Text] [Related]
20. Tacrolimus for rescue of refractory renal allograft rejection. Jordan ML; Naraghi R; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE Transplant Proc; 1998 Jun; 30(4):1257-60. PubMed ID: 9636511 [No Abstract] [Full Text] [Related] [Next] [New Search]